Samsung Biologics to expand manufacturing in South Korea; WuXi AppTec expects up to 7% revenue growth this year
Samsung Biologics is preparing to expand its manufacturing networks.
On Monday, the South Korean contract manufacturer posted financial results for the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
